Announcements

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Tumor Microenvironment”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Infectious Agents and Cancer”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Pediatric Oncology”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in Cancers (ISSN: 2072-6694) in the Section “Transplant Oncology”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Therapy”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of tumor microenvironment. The paper list is as follows:

“Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer”
by Manuel Sánchez-de-la-Torre, Carolina Cubillos, Olivia J. Veatch, Francisco Garcia-Rio, David Gozal and Miguel Angel Martinez-Garcia
Cancers 2023, 15(4), 1061; https://doi.org/10.3390/cancers15041061
Available online: https://www.mdpi.com/2072-6694/15/4/1061

“Optical Genome Mapping for Cytogenetic Diagnostics in AML”
by Verena Nilius-Eliliwi, Wanda M. Gerding, Roland Schroers, Huu Phuc Nguyen and Deepak B. Vangala
Cancers 2023, 15(6), 1684; https://doi.org/10.3390/cancers15061684
Available online: https://www.mdpi.com/2072-6694/15/6/1684

“Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers”
by Kellen Wright, Thuc Ly, Matthew Kriet, Andras Czirok and Sufi Mary Thomas
Cancers 2023, 15(6), 1899; https://doi.org/10.3390/cancers15061899
Available online: https://www.mdpi.com/2072-6694/15/6/1899

“Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer”
by Kohei Okuyama, Keiji Suzuki and Souichi Yanamoto
Cancers 2023, 15(4), 1111; https://doi.org/10.3390/cancers15041111
Available online: https://www.mdpi.com/2072-6694/15/4/1111

“Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?”
by Amol Gupta, Razelle Kurzrock and Jacob J. Adashek
Cancers 2023, 15(5), 1578; https://doi.org/10.3390/cancers15051578
Available online: https://www.mdpi.com/2072-6694/15/5/1578

“Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer”
by Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Ferial Alloush, Yumna Omarzai and Robert Poppiti
Cancers 2023, 15(5), 1621; https://doi.org/10.3390/cancers15051621
Available online: https://www.mdpi.com/2072-6694/15/5/1621

“Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma”
by Yun-Yun Tao, Yue Shi, Xue-Qin Gong, Li Li, Zu-Mao Li, Lin Yang and Xiao-Ming Zhang
Cancers 2023, 15(2), 365; https://doi.org/10.3390/cancers15020365
Available online: https://www.mdpi.com/2072-6694/15/2/365

“Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect”
by Hongyang Deng, Jiaxing Zhang, Fahong Wu, Fengxian Wei, Wei Han, Xiaodong Xu and Youcheng Zhang
Cancers 2023, 15(4), 1169; https://doi.org/10.3390/cancers15041169
Available online: https://www.mdpi.com/2072-6694/15/4/1169

“PARP Inhibitors in Breast and Ovarian Cancer”
by Samuel S. Y. Wang, Yeo Ee Jie, Sim Wey Cheng, Goh Liuh Ling and Heong Valerie Yue Ming
Cancers 2023, 15(8), 2357; https://doi.org/10.3390/cancers15082357
Available online: https://www.mdpi.com/2072-6694/15/8/2357

“Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice”
by Anna Chen, Ines Neuwirth and Dietmar Herndler-Brandstetter
Cancers 2023, 15(11), 2989; https://doi.org/10.3390/cancers15112989
Available online: https://www.mdpi.com/2072-6694/15/11/2989

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer therapy. The paper list is as follows:

“Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer”
by Abhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, Ilana Schlam, Sarah Sammons, Sara M. Tolaney and Paolo Tarantino
Cancers 2023, 15(7), 2015; https://doi.org/10.3390/cancers15072015
Available online: https://www.mdpi.com/2072-6694/15/7/2015

“Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review”
by Celia García-Chico, Susana López-Ortiz, Saúl Peñín-Grandes, José Pinto-Fraga, Pedro L. Valenzuela, Enzo Emanuele, Claudia Ceci, Grazia Graziani, Carmen Fiuza-Luces, Simone Lista et al.
Cancers 2023, 15(1), 324; https://doi.org/10.3390/cancers15010324
Available online: https://www.mdpi.com/2072-6694/15/1/324

“The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited”
by Kevin Dzobo, Dimakatso A. Senthebane and Collet Dandara
Cancers 2023, 15(2), 376; https://doi.org/10.3390/cancers15020376
Available online: https://www.mdpi.com/2072-6694/15/2/376

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(4), 1320; https://doi.org/10.3390/cancers15041320
Available online: https://www.mdpi.com/2072-6694/15/4/1320

“Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management”
by Chengjun Yao, Haiying Zhou, Yanzhao Dong, Ahmad Alhaskawi, Sohaib Hasan Abdullah Ezzi, Zewei Wang, Jingtian Lai, Vishnu Goutham Kota, Mohamed Hasan Abdulla Hasan Abdulla and Hui Lu
Cancers 2023, 15(4), 1077; https://doi.org/10.3390/cancers15041077
Available online: https://www.mdpi.com/2072-6694/15/4/1077

“Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer”
by Houssein Chhouri, David Alexandre and Luca Grumolato
Cancers 2023, 15(2), 504; https://doi.org/10.3390/cancers15020504
Available online: https://www.mdpi.com/2072-6694/15/2/504

“Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment”
by Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J. H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot et al.
Cancers 2023, 15(7), 2119; https://doi.org/10.3390/cancers15072119
Available online: https://www.mdpi.com/2072-6694/15/7/2119

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities”
by Kang Qin, Lingzhi Hong, Jianjun Zhang and Xiuning Le
Cancers 2023, 15(3), 612; https://doi.org/10.3390/cancers15030612
Available online: https://www.mdpi.com/2072-6694/15/3/612

“Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer”
by Éabha O’Sullivan, Anna Keogh, Brian Henderson, Stephen P. Finn, Steven G. Gray and Kathy Gately
Cancers 2023, 15(6), 1635; https://doi.org/10.3390/cancers15061635
Available online: https://www.mdpi.com/2072-6694/15/6/1635

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of infectious agents and cancer. The paper list is as follows:

“Gut Microbiota and Breast Cancer: The Dual Role of Microbes”
by Ana Isabel Álvarez-Mercado, Ana del Valle Cano, Mariana F. Fernández and Luis Fontana
Cancers 2023, 15(2), 443; https://doi.org/10.3390/cancers15020443
Available online: https://www.mdpi.com/2072-6694/15/2/443

“Genotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer”
by Ya Wang and Kai Fu
Cancers 2023, 15(4), 1152; https://doi.org/10.3390/cancers15041152
Available online: https://www.mdpi.com/2072-6694/15/4/1152

“EBV and Lymphomagenesis”
by Daniel G. Sausen, Ayeman Basith and Syed Muqeemuddin
Cancers 2023, 15(7), 2133; https://doi.org/10.3390/cancers15072133
Available online: https://www.mdpi.com/2072-6694/15/7/2133

“Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma”
by Roland Houben, Büke Celikdemir, Thibault Kervarrec and David Schrama
Cancers 2023, 15(2), 444; https://doi.org/10.3390/cancers15020444
Available online: https://www.mdpi.com/2072-6694/15/2/444

“Relationship of Post-Transplant Lymphoproliferative Disorders (PTLD) Subtypes and Clinical Outcome in Pediatric Heart Transplant Recipients: A Retrospective Single Institutional Analysis/Experience of 558 Patients”
by Yan Liu, Billy C. Wang, Craig W. Zuppan, Peter Chau, James Fitts, Richard Chinnock and Jun Wang
Cancers 2023, 15(3), 976; https://doi.org/10.3390/cancers15030976
Available online: https://www.mdpi.com/2072-6694/15/3/976

“Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis”
by Efstathia Liatsou, Ioannis Ntanasis-Stathopoulos, Stavros Lykos, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, Theodoros N. Sergentanis and Evangelos Terpos
Cancers 2023, 15(8), 2266; https://doi.org/10.3390/cancers15082266
Available online: https://www.mdpi.com/2072-6694/15/8/2266

“SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines”
by Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Dmitry V. Yanvarev, Olga I. Kechko, Vladimir A. Mitkevich, Pavel O. Vorobyev, Vyacheslav S. Fedorov et al.
Cancers 2023, 15(3), 632; https://doi.org/10.3390/cancers15030632
Available online: https://www.mdpi.com/2072-6694/15/3/632

“Impact of Preventive Strategies on HPV-Related Diseases: Ten-Year Data from the Italian Hospital Admission Registry”
by Vincenzo Restivo, Giuseppa Minutolo, Marianna Maranto, Antonio Maiorana, Francesco Vitale, Alessandra Casuccio and Emanuele Amodio
Cancers 2023, 15(5), 1452; https://doi.org/10.3390/cancers15051452
Available online: https://www.mdpi.com/2072-6694/15/5/1452

“COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study”
by Joaquín Martínez-López, Javier De la Cruz, Rodrigo Gil-Manso, Adrián Alegre, Javier Ortiz, Pilar Llamas, Yolanda Martínez, José-Ángel Hernández-Rivas, Isabel González-Gascón, Celina Benavente et al.
Cancers 2023, 15(5), 1497; https://doi.org/10.3390/cancers15051497
Available online: https://www.mdpi.com/2072-6694/15/5/1497

“The Role of the Microbiota in Esophageal Cancer”
by Clara Moreira, Ceu Figueiredo and Rui Manuel Ferreira
Cancers 2023, 15(9), 2576; https://doi.org/10.3390/cancers15092576
Available online: https://www.mdpi.com/2072-6694/15/9/2576

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of pediatric oncology. The list of papers is as follows:

“Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology”
by Kristin E. Zorn, Ashley M. Cunningham, Alison E. Meyer, Karen Sue Carlson and Sridhar Rao
Cancers 2023, 15(5), 1443; https://doi.org/10.3390/cancers15051443
Available online: https://www.mdpi.com/2072-6694/15/5/1443

“Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research”
by Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini and Katia Scotlandi
Cancers 2023, 15(3), 588; https://doi.org/10.3390/cancers15030588
Available online: https://www.mdpi.com/2072-6694/15/3/588

“Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated”
by Alexandra McLean Stevens, Eric S. Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Melanie B. Bernhardt, Allison Weisnicht, Wesley T. Smith, Noah J. Keogh et al.
Cancers 2023, 15(4), 1344; https://doi.org/10.3390/cancers15041344
Available online: https://www.mdpi.com/2072-6694/15/4/1344

“Biological Role and Clinical Implications of MYOD1^L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644

“Adapting the Voicing My CHOiCES Advance Care Planning Communication Guide for Australian Adolescents and Young Adults with Cancer: Appropriateness, Acceptability, and Considerations for Clinical Practice”
by Ursula M. Sansom-Daly, Megan Zhang, Holly E. Evans, Jordana McLoone, Lori Wiener, Richard J. Cohn, Antoinette Anazodo, Pandora Patterson and Claire E. Wakefield
Cancers 2023, 15(7), 2129; https://doi.org/10.3390/cancers15072129
Available online: https://www.mdpi.com/2072-6694/15/7/2129

“Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature”
by Louisa Taylor, Philippa K. Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian D. Kerr and Beth Coyle
Cancers 2023, 15(4), 1086; https://doi.org/10.3390/cancers15041086
Available online: https://www.mdpi.com/2072-6694/15/4/1086

“Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma”
by Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang and Hongwei Zhang
Cancers 2023, 15(3), 602; https://doi.org/10.3390/cancers15030602
Available online: https://www.mdpi.com/2072-6694/15/3/602

“Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

“Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

“Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience”
by Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian et al.
Cancers 2023, 15(7), 1983; https://doi.org/10.3390/cancers15071983
Available online: https://www.mdpi.com/2072-6694/15/7/1983

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Drug Development”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office